Advertisement
Advertisement

ASMB

ASMB logo

Assembly Biosciences, Inc

27.84
USD
Sponsored
-1.03
-3.58%
Mar 27, 10:52 UTC -4
Open

ASMB Earnings Reports

Positive Surprise Ratio

ASMB beat 26 of 38 last estimates.

68%

Next Report

Date of Next Report
May 06, 2026
Estimate for Q1 26 (Revenue/ EPS)
$9.49M
/
-$0.60
Implied change from Q4 25 (Revenue/ EPS)
-77.66%
/
-124.19%
Implied change from Q1 25 (Revenue/ EPS)
+0.71%
/
-48.72%

Assembly Biosciences, Inc earnings per share and revenue

On Mar 19, 2026, ASMB reported earnings of 2.48 USD per share (EPS) for Q4 25, beating the estimate of -0.66 USD, resulting in a 474.06% surprise. Revenue reached 42.47 million, compared to an expected 7.57 million, with a 460.93% difference. The market reacted with a -0.04% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 4 analysts forecast an EPS of -0.60 USD, with revenue projected to reach 9.49 million USD, implying an decrease of -124.19% EPS, and decrease of -77.66% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Taysha Gene Therapies, Inc. Common Stock
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.09
Actual
-$0.08
Surprise
+18.45%
logo
Sol-Gel Technologies Ltd. Ordinary Shares
Report Date
Mar 23, 2026 For Q4 25
Estimate
$0.39
Actual
-
Surprise
-
FAQ
For Q4 2025, Assembly Biosciences, Inc reported EPS of $2.48, beating estimates by 474.06%, and revenue of $42.47M, 460.93% above expectations.
The stock price moved down -0.04%, changed from $27.52 before the earnings release to $27.51 the day after.
The next earning report is scheduled for May 06, 2026.
Based on 4 analysts, Assembly Biosciences, Inc is expected to report EPS of -$0.60 and revenue of $9.49M for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement